REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the appointment of Mehul Joshi as Chief Financial Officer, effective April 3, 2024. He succeeds John McKune, who has served as the Company's Interim Chief Financial Officer since October 10, 2023, and will transition to his prior role as Vice President, Corporate Controller.
"Mehul is an exceptionally accomplished financial executive and I am excited to welcome him to our leadership team. His proven track record of leading global finance teams within large, diversified companies makes him the right fit for Pulmonx as we continue to execute on our multifaceted growth strategies and I look forward to working closely with him," said Steve Williamson, President and Chief Executive Officer. "I would also like to thank John McKune for stepping into the role of Interim Chief Financial Officer and for his continued leadership on the finance team."
"I am thrilled to join Pulmonx as Chief Financial Officer at this exciting time for the company," stated Mehul Joshi. "I look forward to working alongside Steve and the rest of the team and leveraging my operational experience to advance the company's goal of expanding patient access to life-changing Zephyr Valve treatment while delivering shareholder value."
About Mehul Joshi
Mehul Joshi brings over 30 years of experience in finance, ...